All-cause, liver-related, and non-liver-related mortality among hcv-infected individuals in the general US population

Clinical Infectious Diseases

Volumn 53, Issue 2, 2011, Pages 150-157

  El Kamary, Samer S ^a,b   Jhaveri, Ravi ^c,d   Shardell, Michelle D ^a  

^a University of Maryland School of Medicine Center for Vaccine Development   (United States)

^b Department of Pediatrics ^*  (United States)

^c Division of Digestive Diseases   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; UNITED STATES;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 79959722134     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir306     Document Type: Article

References (37)

1. Global Burden Of Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 2004; 44:20-9.
2. Heintges T, Wands JR. Hepatitis C virus: epidemiology and transmission. Hepatology 1997; 26:521-6. (Pubitemid 27392339)
3. Kenny-Walsh E. Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group. N Engl J Med 1999; 340:1228-33. (Pubitemid 29181642)
4. Shakil AO, Conry-Cantilena C, Alter HJ, et al. Volunteer blood donors with antibody to hepatitis C virus: clinical, biochemical, virologic, and histologic features. The Hepatitis C Study Group. Ann Intern Med 1995; 123:330-7.
5. Vogt M, Lang T, Frosner G, et al. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening. N Engl J Med 1999; 341:866-70. (Pubitemid 29427048)
6. Wasley A, Grytdal S, Gallagher K. Surveillance for acute viral hepatitis- United States, 2006. MMWR Surveill Summ 2008; 57:1-24.
7. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341:556-62. (Pubitemid 29384163)
8. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144:705-14. (Pubitemid 46780630)
9. Verna EC, Brown RS Jr. Hepatitis C virus and liver transplantation. Clin Liver Dis 2006; 10:919-40. (Pubitemid 44895436)
10. National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C. Hepatology 1997; 26(3 Suppl 1):2S-10.
11. Hoofnagle JH. Hepatitis C: the clinical spectrum of disease. Hepatology 1997; 26(3 Suppl 1):15S-20.
12. Centers for Disease Control and Prevention. Statistics and surveillance: Disease burden from viral Hepatitis A, B, and C in the United States. 2009. Available at: http://www.cdc.gov/hepatitis/statistics.htm. Accessed 2 May 2011.
13. Manos MM, Leyden WA, Murphy RC, Terrault NA, Bell BP. Limitations of conventionally derived chronic liver disease mortality rates: results of a comprehensive assessment. Hepatology 2008; 47:1150-7. (Pubitemid 351547901)
14. Wise M, Bialek S, Finelli L, Bell BP, Sorvillo F. Changing trends in hepatitis C-related mortality in the United States, 1995-2004. Hepatology 2008; 47:1128-35. (Pubitemid 351547899)
15. National Center for Health Statistics, Centers for Disease Control and Prevention Web Site. National Health and Nutrition Examination Survey. Available at: http://www.cdc.gov/nchs/nhanes/nh3data.htm. Accessed 2 May 2011.
16. Ezzati TM, Massey JT, Waksberg J, Chu A, Maurer KR. Sample design: Third National Health and Nutrition Examination Survey. Vital Health Stat 2 1992: (113)1-35.
17. Gunter EW, Lewis BL, Koncikowski SM. Laboratory methods used for the third National Health and Nutrition Examination Survey (NHANES III), 1988-1994. Atlanta, GA: National Center for Environmental Health, Centers for Disease Control and Prevention, Public Health Service, US Department of Health and Human Services, 1996.
18. United States. Health Care Financing Administration. The International classification of diseases, 9th revision, clinical modification: ICD-9-CM. 4th ed. Washington, DC: US Dept of Health and Human Services, Public Health Service For sale by the Supt. of Docs., US GPO, 1991.
19. World Health Organization, WHO Collaborating Centres for Classification of Diseases. International statistical classification of diseases and related health problems. 10th revision. ed. Geneva: World Health Organization, 1992.
20. R Development Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing, 2006.
21. Korn EL, Graubard BI. Analysis of health surveys. New York, NY: Wiley, 1999.
22. Binder DA. Fitting Cox's proportional hazards models from survey data. Biometrika 1992; 79:139-47.
23. Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology 2004; 39:476-83. (Pubitemid 38222189)
24. Mohsen AH. The epidemiology of hepatitis C in a UK health regional population of 5.12 million. Gut 2001; 48:707-13. (Pubitemid 32378595)
25. Neal KR, Ramsay S, Thomson BJ, Irving WL. Excess mortality rates in a cohort of patients infected with the hepatitis C virus: a prospective study. Gut 2007; 56:1098-104. (Pubitemid 47123240)
26. Prasad L, Spicher VM, Negro F, Rickenbach M, Zwahlen M. Little evidence that hepatitis C virus leads to a higher risk of mortality in the absence of cirrhosis and excess alcohol intake: the Swiss Hepatitis C Cohort Study. J Viral Hepat 2009; 16:644-9.
27. Seeff LB, Hollinger FB, Alter HJ, et al. Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: a National Heart, Lung, and Blood Institute collaborative study. Hepatology 2001; 33:455-63. (Pubitemid 32119036)
28. Hammett TM, Harmon MP, Rhodes W. The burden of infectious disease among inmates of and releasees from US correctional facilities, 1997. Am J Public Health 2002; 92:1789-94.
29. Mason AL, Lau JY, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999; 29:328-33. (Pubitemid 29088433)
30. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133:592-9.
31. Haji SA, Starling RC, Avery RK, et al. Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation. J Heart Lung Transplant 2004; 23:277-83. (Pubitemid 38333084)
32. Ishizaka N, Ishizaka Y, Takahashi E, et al. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet 2002; 359:133-5. (Pubitemid 34112545)
33. Vassalle C, Masini S, Bianchi F, Zucchelli GC. Evidence for association between hepatitis C virus seropositivity and coronary artery disease. Heart 2004; 90:565-6. (Pubitemid 38530180)
34. Bedimo R, Westfall AO, Mugavero M, Drechsler H, Khanna N, Saag M. Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients. HIV Med. 2010; 11:462-8.
35. Hansen AB, Gerstoft J, Kronborg G, Pedersen C, Sorensen HT, Obel N. Mortality in siblings of patients coinfected with HIV and hepatitis C virus. J Infect Dis 2007; 195:230-5. (Pubitemid 46080055)
36. Tillmann HL, Thursz M. Hepatitis C virus infection-its role in pathogenesis. J Infect Dis 2007; 195:168-70. (Pubitemid 46080047)
37. Guiltinan AM, Kaidarova Z, Custer B, et al. Increased all-cause, liver, and cardiac mortality among hepatitis C virus-seropositive blood donors. Am J Epidemiol 2008; 167:743-50. (Pubitemid 351430942)